Correlation Between Capri Holdings and ASTELLAS PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Capri Holdings and ASTELLAS PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capri Holdings and ASTELLAS PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capri Holdings and ASTELLAS PHARMA UNSPADR, you can compare the effects of market volatilities on Capri Holdings and ASTELLAS PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capri Holdings with a short position of ASTELLAS PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capri Holdings and ASTELLAS PHARMA.

Diversification Opportunities for Capri Holdings and ASTELLAS PHARMA

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Capri and ASTELLAS is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Capri Holdings and ASTELLAS PHARMA UNSPADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ASTELLAS PHARMA UNSPADR and Capri Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capri Holdings are associated (or correlated) with ASTELLAS PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ASTELLAS PHARMA UNSPADR has no effect on the direction of Capri Holdings i.e., Capri Holdings and ASTELLAS PHARMA go up and down completely randomly.

Pair Corralation between Capri Holdings and ASTELLAS PHARMA

Given the investment horizon of 90 days Capri Holdings is expected to under-perform the ASTELLAS PHARMA. In addition to that, Capri Holdings is 2.01 times more volatile than ASTELLAS PHARMA UNSPADR. It trades about -0.02 of its total potential returns per unit of risk. ASTELLAS PHARMA UNSPADR is currently generating about -0.02 per unit of volatility. If you would invest  1,255  in ASTELLAS PHARMA UNSPADR on September 1, 2024 and sell it today you would lose (310.00) from holding ASTELLAS PHARMA UNSPADR or give up 24.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.06%
ValuesDaily Returns

Capri Holdings  vs.  ASTELLAS PHARMA UNSPADR

 Performance 
       Timeline  
Capri Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Capri Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
ASTELLAS PHARMA UNSPADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ASTELLAS PHARMA UNSPADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Capri Holdings and ASTELLAS PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Capri Holdings and ASTELLAS PHARMA

The main advantage of trading using opposite Capri Holdings and ASTELLAS PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capri Holdings position performs unexpectedly, ASTELLAS PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ASTELLAS PHARMA will offset losses from the drop in ASTELLAS PHARMA's long position.
The idea behind Capri Holdings and ASTELLAS PHARMA UNSPADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets